These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15320808)

  • 1. AT1 receptor antagonists.
    Verheijen I; Vanderheyden PM; De Backer JP; Vauquelin G
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):69-77. PubMed ID: 15320808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting angiotensin type 1 receptor binding and protection by candesartan: comparison with other biphenyl-tetrazole sartans.
    Vauquelin G; Fierens F; Van Liefde I
    J Hypertens Suppl; 2006 Mar; 24(1):S23-30. PubMed ID: 16601569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors.
    Vanderheyden PM; Fierens FL; De Backer JP; Fraeyman N; Vauquelin G
    Br J Pharmacol; 1999 Feb; 126(4):1057-65. PubMed ID: 10193788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptors.
    Verheijen I; Fierens FL; Debacker JP; Vauquelin G; Vanderheyden PM
    Fundam Clin Pharmacol; 2000; 14(6):577-85. PubMed ID: 11206708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic characterization of AT1 receptor antagonists with label-free dynamic mass redistribution assays.
    Qu L; Wang J; Hou T; Zhou H; Wang Z; Zhang X; Liang X
    J Pharmacol Toxicol Methods; 2020; 102():106682. PubMed ID: 32087363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
    Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
    Fierens FL; Vanderheyden PM; De Backer JP; Vauquelin G
    Eur J Pharmacol; 1999 May; 372(2):199-206. PubMed ID: 10395100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptors.
    Vanderheyden PM; Verheijen I; Fierens FL; DeBacker JP; Vauquelin G
    Pharm Res; 2000 Dec; 17(12):1482-8. PubMed ID: 11303957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of candesartan on human AT1 receptor-expressing Chinese hamster ovary cells.
    Vauquelin G; Fierens FL; De Backer JP; Vanderheyden PM
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S15-7. PubMed ID: 9892135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog.
    Lee BH; Lee SH; Jung YS; Seo HW; Yoo SE; Shin HS
    J Pharm Pharmacol; 1999 Oct; 51(10):1191-200. PubMed ID: 10579691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sartan-AT1 receptor interactions: in vitro evidence for insurmountable antagonism and inverse agonism.
    Van Liefde I; Vauquelin G
    Mol Cell Endocrinol; 2009 Apr; 302(2):237-43. PubMed ID: 18620019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of saponin and filipin on antagonist binding to AT 1 receptors in intact cells.
    Verheijen I; Tourlousse D; Vanderheyden PM; Backer JP; Vauquelin G
    Biochem Pharmacol; 2004 Apr; 67(8):1601-6. PubMed ID: 15041477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional studies but not receptor binding can distinguish surmountable from insurmountable AT1 antagonism.
    Panek RL; Lu GH; Overhiser RW; Major TC; Hodges JC; Taylor DG
    J Pharmacol Exp Ther; 1995 May; 273(2):753-61. PubMed ID: 7752078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants for binding, activation, and functional selectivity of the angiotensin AT1 receptor.
    Balakumar P; Jagadeesh G
    J Mol Endocrinol; 2014 Oct; 53(2):R71-92. PubMed ID: 25013233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctions between non-peptide angiotensin II AT1-receptor antagonists.
    Vauquelin G; Fierens FL; Verheijen I; Vanderheyden PM
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S24-S31. PubMed ID: 28095245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
    Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
    Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Network leaning" as a mechanism of insurmountable antagonism of the angiotensin II type 1 receptor by non-peptide antagonists.
    Takezako T; Gogonea C; Saad Y; Noda K; Karnik SS
    J Biol Chem; 2004 Apr; 279(15):15248-57. PubMed ID: 14754891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Candesartan cilexetil: pharmacological properties and protective effects against organ damage of a novel nonpeptide angiotensin II-receptor antagonist].
    Inada Y; Naka T
    Nihon Yakurigaku Zasshi; 2000 Mar; 115(3):151-60. PubMed ID: 10876800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists.
    Vauquelin G; Morsing P; Fierens FL; De Backer JP; Vanderheyden PM
    Biochem Pharmacol; 2001 Feb; 61(3):277-84. PubMed ID: 11172731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.